Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<jats:title>ABSTRACT</jats:title><jats:p>Injections with a hypodermic needle and syringe (HNS) are the current standard of care globally, but the use of needles is not without limitation. While a plethora of needle-free injection devices exist, vaccine reformulation is costly and presents a barrier to their widespread clinical application. To provide a simple, needle-free, and broad-spectrum protein antigen delivery platform, we developed novel potassium-doped hydroxyapatite (K-Hap) microparticles with improved protein loading capabilities that can provide sustained local antigen presentation and release. K-Hap showed increased protein adsorption over regular hydroxyapatite (<jats:italic>P</jats:italic>&lt; 0.001), good structural retention of the model antigen (CRM<jats:sub>197</jats:sub>) with 1% decrease in α-helix content and no change in β-sheet content upon adsorption, and sustained release<jats:italic>in vitro</jats:italic>. Needle-free intradermal powder inoculation with K-Hap–CRM<jats:sub>197</jats:sub>induced significantly higher IgG1 geometric mean titers (GMTs) than IgG2a GMTs in a BALB/c mouse model (<jats:italic>P</jats:italic>&lt; 0.001) and induced IgG titer levels that were not different from the current clinical standard (<jats:italic>P</jats:italic>&gt; 0.05), namely, alum-adsorbed CRM<jats:sub>197</jats:sub>by intramuscular (i.m.) delivery. The presented results suggest that K-Hap microparticles may be used as a novel needle-free delivery vehicle for some protein antigens.</jats:p>

Original publication

DOI

10.1128/cvi.00121-15

Type

Journal article

Journal

Clinical and Vaccine Immunology

Publisher

American Society for Microbiology

Publication Date

05/2015

Volume

22

Pages

586 - 592